Oral Care Heavyweights Disagree On Plaque Claim Support, Stannous Fluoride
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble and Pfizer take opposing views on the way therapeutic standalone antiplaque claims should be regulated in comments submitted to FDA Feb. 20